Optimizing the TRUNCATE strategy to further improve outcomes from two-month treatment for rifampicin-susceptible tuberculosis: Health economics presentation
Union World Conference on Lung Health
Saved in:
Main Authors: | Schaffer, Elisabeth, Prem, Kiesha, Sari, Intan, Wee, Hwee Lin, Paton, Nicholas Iain James |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
2024
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/248627 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Susceptibility of Rifampicin-Isoniazid Resistant Mycobacterium Tuberculosis Isolates Against Levofloxacin
by: Alvin Hartanto Kurniawan, et al.
Published: (2016) -
Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis
by: S. Foongladda, et al.
Published: (2018) -
T-cell subpopulations in tuberculosis and the effects of rifampicin
by: A. Vidhidharm, et al.
Published: (2018) -
Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
by: Blessed Winston Aruldhas, et al.
Published: (2020) -
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation
by: Wasana Prasitsuebsai, et al.
Published: (2018)